# Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse

> **NCT00699010** · PHASE2 · COMPLETED · sponsor: **Acura Pharmaceuticals Inc.** · enrollment: 30 (actual)

## Conditions studied

- Opioid Abuse

## Interventions

- **DRUG:** Acurox 5/30mg taken first
- **DRUG:** Oxycodone 5mg taken first

## Key facts

- **NCT ID:** NCT00699010
- **Lead sponsor:** Acura Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699010, "Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00699010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*